ASTM E1589-21
(Practice)Standard Practice for Evaluation of First Aid Antiseptic Drug Products
Standard Practice for Evaluation of First Aid Antiseptic Drug Products
SIGNIFICANCE AND USE
5.1 The procedures in this practice should be used for in vivo evaluation of the antimicrobial activity of drug products applied topically to the skin that are intended to help prevent infection in minor cuts, scrapes and burns.
5.1.1 This practice is applicable for testing liquids, ointments, powders, films, or dressings, containing or impregnated with an antimicrobial agent, for their effect to reduce an enhanced skin microflora or their effects to suppress the growth of the skin flora, or both.
SCOPE
1.1 The tests described in this practice are designed to evaluate antimicrobial agents in formulations intended for use as first aid antiseptic products for their ability to reduce or suppress the growth, or both, of the skin microflora.
1.2 A knowledge of microbiological techniques is required for these procedures.
1.3 Performance of this procedure requires the knowledge of regulations pertaining to the protection of human subjects. (See CFR Parts 50 and 56.)
1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.6 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
General Information
Buy Standard
Standards Content (Sample)
This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation: E1589 − 21
Standard Practice for
1
Evaluation of First Aid Antiseptic Drug Products
This standard is issued under the fixed designation E1589; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope E2756 Terminology Relating to Antimicrobial and Antiviral
Agents
1.1 The tests described in this practice are designed to
3
2.2 Federal Standards:
evaluate antimicrobial agents in formulations intended for use
CFR Parts 50 and 56 Code of Federal Regulations: Protec-
as first aid antiseptic products for their ability to reduce or
tion of Human Subjects; Institutional Review Boards
suppress the growth, or both, of the skin microflora.
1.2 A knowledge of microbiological techniques is required
3. Terminology
for these procedures.
3.1 For definitions of terms used in this practice, refer to
1.3 Performance of this procedure requires the knowledge
E2756 Terminology Relating to Antimicrobial and Antiviral
of regulations pertaining to the protection of human subjects.
Agents.
(See CFR Parts 50 and 56.)
3.2 Definitions of Terms Specific to This Standard:
1.4 The values stated in SI units are to be regarded as
3.2.1 active ingredient, n—a substance performing a func-
standard. No other units of measurement are included in this
tion defined by this method.
standard.
3.2.2 neutralizer, n—a procedure or chemical agent used to
1.5 This standard does not purport to address all of the
inactivate,neutralize,orquenchthemicrobiocidalpropertiesof
safety concerns, if any, associated with its use. It is the
an antimicrobial agent.
responsibility of the user of this standard to establish appro-
3.2.3 sampling fluid, n—a recovery fluid that may or may
priate safety, health, and environmental practices and deter-
not contain a neutralizer to inactivate the active ingredients in
mine the applicability of regulatory limitations prior to use.
test and internal reference formulations.
1.6 This international standard was developed in accor-
3.2.4 test formulation, n—a formulation containing an ac-
dance with internationally recognized principles on standard-
tive ingredient(s).
ization established in the Decision on Principles for the
Development of International Standards, Guides and Recom-
4. Summary of Practice
mendations issued by the World Trade Organization Technical
Barriers to Trade (TBT) Committee. 4.1 These test procedures describe standard in vivo tech-
niques to determine the following:
2. Referenced Documents 4.1.1 Effect of the Test Formulation to Reduce anArtificially
2
Enhanced Skin Microbial Flora—The forearms of subjects are
2.1 ASTM Standards:
occluded for 48 h prior to application of the test formulation to
D1193 Specification for Reagent Water
increase the microbial population on the skin of the volar
E1054 Practices for Evaluation of Inactivators ofAntimicro-
forearm surface. At treatment the occlusion material is re-
bial Agents
moved and the skin is allowed to dry, the test formulation is
E1874 Test Method for Recovery of Microorganisms From
then applied to selected sites. At a pre-determined time(s)
Skin using the Cup Scrub Technique
following application, the sites are microbiologically sampled
and the samples are plated for total aerobic bacteria count. The
counts obtained from the treated sites are compared to counts
1
This practice is under the jurisdiction ofASTM Committee E35 on Pesticides,
obtained from untreated occluded sites.
Antimicrobials, and Alternative Control Agents and is the direct responsibility of
4.1.2 Effect of the Test Formulation to Suppress the Growth
Subcommittee E35.15 on Antimicrobial Agents.
Current edition approved Oct. 1, 2021. Published January 2022. Originally
of Normal Skin Flora When Applied As a Dressing—The
approved in 1994. Last previous edition approved in 2015 as E1589 – 05(2015).
dressingsareappliedtotheforearmfor24h.Thedensityofthe
DOI: 10.1520/E1589-21.
2
For referenced ASTM standards, visit the ASTM website, www.astm.org, or
contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
3
Standards volume information, refer to the standard’s Document Summary page on Available from U.S. Government Publishing Office, 732 N. Capitol St., NW,
the ASTM website. Washington DC, 20401-0001, http://www.gpo.gov.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1
---------------------- Page: 1 ----------------------
E1589 − 21
4
residen
...
This document is not an ASTM standard and is intended only to provide the user of an ASTM standard an indication of what changes have been made to the previous version. Because
it may not be technically possible to adequately depict all changes accurately, ASTM recommends that users consult prior editions as appropriate. In all cases only the current version
of the standard as published by ASTM is to be considered the official document.
Designation: E1589 − 05 (Reapproved 2015) E1589 − 21
Standard Test Method Practice for
1
Evaluation of First Aid Antiseptic Drug Products
This standard is issued under the fixed designation E1589; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope
1.1 The tests described in this test method are designed to evaluate antimicrobial agents in formulations intended for use as first
aid antiseptic products for their ability to reduce or suppress the growth, or both, of the skin microflora.
1.2 A knowledge of microbiological techniques is required for these procedures.
1.3 Performance of this procedure requires the knowledge of regulations pertaining to the protection of human subjects. (See CFR
Parts 50 and 56.)
1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility
of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory
limitations prior to use.
2. Referenced Documents
2
2.1 ASTM Standards:
D1193 Specification for Reagent Water
E1054 Practices for Evaluation of Inactivators of Antimicrobial Agents
3
2.2 Federal Standards:
CFR Parts 50 and 56
3. Terminology
3.1 active ingredient, n—a substance performing a function defined by this method.
3.2 neutralization, n—a process which results in quenching or inactivating inactivation of the antimicrobial activity of a
formulation. This may be achieved with dilution of the formulation, or with the use of chemical agents, called neutralizers.
3.3 neutralizer, n—a procedure or chemical agent used to inactivate, neutralize, or quench the microbiocidal properties of an
antimicrobial agent.
1
This test method practice is under the jurisdiction of ASTM Committee E35 on Pesticides, Antimicrobials, and Alternative Control Agents and is the direct responsibility
of Subcommittee E35.15 on Antimicrobial Agents.
Current edition approved Oct. 1, 2015Oct. 1, 2021. Published November 2015January 2022. Originally approved in 1994. Last previous edition approved in 20102015
as E1589 – 05(2010).(2015). DOI: 10.1520/E1589-05R15.10.1520/E1589-21.
2
For referenced ASTM standards, visit the ASTM website, www.astm.org, or contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM Standards
volume information, refer to the standard’s Document Summary page on the ASTM website.
3
Available from U.S. Government Publishing Office, 732 N. Capitol St., NW, Washington DC, 20401-0001, http://www.gpo.gov.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1
---------------------- Page: 1 ----------------------
E1589 − 21
3.4 resident microorganisms, n—microorganisms that live and multiply on skin, forming a permanent population.
3.5 sampling fluid, n—a recovery fluid that may or may not contain a neutralizer to inactivate the active ingredients in test and
internal reference formulations.
3.6 test formulation, n—a formulation containing an active ingredient(s).
3.7 transient microorganisms, n—microorganisms that contaminate but do not normally permanently colonize the skin.
4. Summary of Test Method
4.1 These test methods describe standard in vivo techniques to determine the following:
4.1.1 Effect of the Test Formulation to Reduce an Artificially Enhanced Skin Microbial Flora—The forearms of subjects are
occluded for 48 h prior to application of the test formulation to increase the microbial population on the skin of the volar forearm
surface. At treatment the occlusion material is removed and the skin is allowed to dry, the test formulation is then applied to
selected sites. At a pre-determined time(s) following application, the sites are microbiologically sampled and the samples plated
for total aerobic bacteria count. The counts obtained from the treated sites are compared to counts obtained from untreated
occluded sites.
4.1.2 Effect of the Test Formulation to Suppress the Growth of Normal Skin Flora When Applied As a Dressing—The dressings
are applied to the forearm for 24 h. The density of the resident microorganisms that develop under the dressings are compared
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.